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Reverse transcription loop-mediated isothermal ampliﬁcation (RT-LAMP) and rod-shaped gold nanoparticles
(gold nanorods; GNRs) were employed for nanomolecular detection of human inﬂuenza virus type A RNA.
After cDNA synthesis from the RNA, the primers targeting the M protein gene were used for LAMP
ampliﬁcation. A blue shift from red to purple from the GNR inserting into the LAMP–DNAs can be seen by
the naked eye. Transmission electron microscopy revealed the formation GNR aggregates due to their
interactions with LAMP DNA. One pg RNA (103 dilution of the viral cDNA) was detected using this
colorimetric test. The nanomolecular test showed 100% sensitivity and 95.8% speciﬁcity in comparison to
results by RT-PCR. Also, the test indicated 100% sensitivity and 100% speciﬁcity in comparison to results by
RT-LAMP. The described nanomolecular test could detect human inﬂuenza virus type A RNA in nearly 1 hour.1. Introduction
The inuenza virus is an RNA virus that causes respiratory
illness in humans.1 Global epidemics of inuenza have
repeatedly occurred and many people have died as a result.2
Since this virus is highly contagious, it can spread rapidly.
Hence its early detection in the initial stages is very important
for control of the disease.2 Several molecular methods have
been developed for diagnosis of human inuenza viruses that
employ diﬀerent technologies such as nucleic acid amplica-
tion.3,4 Loop-mediated isothermal amplication (LAMP) has
been used for detection of the human inuenza virus.5 LAMP
amplies DNA in a unique manner (Fig. 1) and produces DNA
amplicons with ladder shape behaviors with gel electropho-
resis.6,7 LAMP DNAs have been named cauliower-like DNAs
and their characteristics have previously been described.7,8 In
LAMP, large fragments of Bst DNA polymerase with strand-
displacement activity are used, and loop and bumper primers
are employed for DNA fabrications.6–8
LAMP technology has previously been reported for molecular
detection of various microorganisms (e.g. human inuenza
virus type A).8–10 The conventional method for analyzing LAMP
DNAs was gel electrophoresis; however, the turbidity derivedulty of Advanced Medical Technologies,
rgan, Iran
logy, Faculty of Medicine, Mazandaran
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98-912-7615950
, Golestan University of Medical Sciences,
hemistry 2014from magnesium pyrophosphate formation in the LAMP reac-
tion introduced a way for visualization of the positive results.11
Also, various methods using uorescent or colorimetric metal
indicators (e.g. calcein) were reported for visualization of the
LAMP byproducts.12
Up to now there has only been one report using LAMP DNAs
with gold nanoparticle probes;13 however, rod-shaped gold
nanoparticles have not been employed with LAMP for rapid
nanomolecular assay. Hence, a nanodiagnostic colorimetric
assay for LAMP DNA detection could improve the LAMP tests for
nanomolecular diagnosis of microorganisms.
The rod-shaped gold nanoparticles are diﬀerent from spher-
ical nanoparticles because of their physical characteristics such
as elongated shapes, surface charge, and unique optical proper-
ties. The Vis-IR spectra of GNRs have two peaks contained
transverse and longitudinal plasmon bands.14,15 The optical
properties of GNRs have been utilised in therapy and diagnos-
tics.16 In this study, nanomolecular detection of human inuenza
virus type A was to be accomplished via LAMP–DNA interactions
with GNRs (Fig. 2). This event has been shown to bring about
changes in the surface plasmon resonance of GNRs17 thus it
could be employed in the design and development of a novel
colorimetric test by rod-shaped gold nanoparticles.2. Results and discussion
2.1. Vis-IR spectra
The spectra of the gold nanorods before and aer the interac-
tion with the cauliower-like DNAs are shown in Fig. 3. The
spectra shown is between 425 and 1075 nm. Two localizedRSC Adv., 2014, 4, 13575–13580 | 13575
Fig. 1 Scheme of loop-mediated isothermal ampliﬁcation: suitable lengths of DNA sequences are present in the target region for LAMP. Each of
the arbitrary sequences is preferably targeted so that a terminal loop structure forms. Strand displacement-type synthesis of DNA is carried out
starting from the annealed F3 primer. The complementary chain separates the strand from the template. A sequence is formed into a single
strand by displacement. Synthesis of the DNA strand is then started from the R1 primer. A primer containing sequence R3 is annealed to R3c of
the template. Strand displacement and synthesis of DNA is then conducted starting from the annealed R3 primer. The R1 primer is annealed to
the portion R2c forming the hairpin loop in two sequences. Synthesis of a nucleotide chain containing a target sequence occurs, the asterisked
arrows indicate the fabrication of various sizes of cauliﬂower-like DNA nanostructures via the incubation time.
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View Article Onlinesurface plasmon resonance (LSPR) peaks were seen in the
visible-infrared region. The peaks were typical for GNR char-
acterization. The visible and infrared peaks of GNRs were seen
at 545 nm and 915 nm before the interaction with cauliower-
like DNAs. The peaks were signicantly reduced aer the
interaction with the LAMP DNAs. Also, the interaction resulted
a positional shi of the visible peak at 525 nm; however, the
infrared peak was kept at 915 nm.
The Vis-IR spectra indicated that the intensity of the second
LSPR-peak was reduced signicantly when compared to those
results from unmodied GNRs (Fig. 1). The reason was explored13576 | RSC Adv., 2014, 4, 13575–13580via transmission electron microscopy of the nanoparticles aer
their interactions by the LAMP DNAs.
2.2. TEM micrographs
The TEM micrograph of the GNRs is shown in Fig. 4a. The
nanoparticles are rod shaped and seem to be 25–30 nm in
length and 5–10 nm in width. The aggregates of the gold
nanorods aer interaction with the LAMP DNAs have been
indicated in Fig. 4b.
The interactions between LAMP DNAs and GNRs resulted in
aggregations of the nanoparticles to cluster forms (Fig. 4b). ItThis journal is © The Royal Society of Chemistry 2014
Fig. 2 The gold nanorod assembly and colorimetric assay. Rod-shape
gold nanoparticles have positive charges on their surface in diH2O due
to the cetyltrimethylammonium bromide (CTAB) cap. LAMP DNAs have
negative charges on their surface due to phosphate groups. The addition
of GNRs to LAMPDNAs produces a purple color as they interact with the
DNA amplicons. Conversely, for the GNRs before interaction to LAMP
DNAs, a red color of separated gold nanorods was observed.
Fig. 4 TEM micrographs of rod-shape gold nanoparticles before (A)
and after (B) interaction with LAMP amplicons.
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View Article Onlineseems the electrostatic interaction between negatively-charged
phosphate groups of DNAs and the positively-charged CTA+
bilayer on GNRs made these nanoparticle complexes.182.3. Colorimetric detection of RT-LAMP DNAs
As shown in Fig. 5a, the sensitivity of the colorimetric assay was
conrmed by loop-mediated amplication of ten-fold serial
dilution RNAs obtained from human inuenza virus type A. The
viral RNA dilutions were also detected by RT-LAMP and gel
electrophoresis stained with SYBRGold (Fig. 5b). The results
show the same sensitivity for detection by LAMP assisted withFig. 3 Vis-IR spectra of the rod-shape gold nanoparticles before (—) an
This journal is © The Royal Society of Chemistry 2014GNRs and the conventional gel electrophoresis. The minimum
dilution of RNAs that was detected by the RT-LAMP–GNR assay
was 103; however, the dilution was also detected by gel elec-
trophoresis and SYBRGold stained agarose gel.
Hence, loop-mediated amplication and the GNRs meant
that the viral cDNA could be colorimetrically detected. This was
similar to the result from gel electrophoresis of the LAMP
product; hence 103 dilution of RT-LAMP amplied viral RNA
could be detected through a color change from red to purple of
the GNR solution (Fig. 5a). There was no need for extra modi-
cations of the gold nanoparticles and buﬀer changes for
interaction with the LAMP mixture. Moreover, the visualization
method could be comparable with the other colorimetric assays
using reagents such as calcein and hydroxynaphthol blue that
are employed for detection of pyrophosphates (as the byprod-
ucts) derived in LAMP reactions.2.4. Clinical performance of the colorimetric assay
Clinical performance of the colorimetric assay was determined
by comparing the GNR–RT-LAMP results to those of RT-PCR.d after (---) interaction with LAMP DNAs.
RSC Adv., 2014, 4, 13575–13580 | 13577
Fig. 5 (A) RT-LAMP–GNR results of 101, 102, 103, 104, 105
dilutions of 1 ng viral RNA (top) and negative results (down) are
determined in purple and red colors, respectively. (B) Gel electro-
phoresis of RT-LAMP results of 1 ng viral RNA with 101, 102, 103,
104, 105 dilutions (lanes 3–7); lanes 2 and 8 are empty; lanes 1 and 9
contained GeneRuller 100–10 000 bp from Fermentas.
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View Article OnlineIncluded in the study, the 125 specimens from 125 patients
received by the laboratory for initial diagnosis by RT-PCR. The
overall results presented in Table 1 indicate that the colori-
metric assay has a sensitivity of 100% and specicity of 95.8% in
comparison to those of RT-PCR. In addition, 100% sensitivity
and 100% specicity were obtained by GNR–RT-LAMPs when
compared to the conventional RT-LAMPs.3. Experimental
3.1. Chemicals and instruments
Isothermal conditions for the LAMP reaction were set using a
cool-hotter dry bath incubator (Kiagen, Iran). TransmissionTable 1 Clinical performance of GNR-LAMP in comparison to RT-PCR
Test and result
RT-PCR
Sensitivity (%) Specicity (%)Positive Negative
GNR-LAMP Positive 29 4 100 95.8
Negative 0 92
13578 | RSC Adv., 2014, 4, 13575–13580electron microscopy was done using a Philips EM028 trans-
mission electron microscope. UV-vis spectra were measured
using a Carry-100 Varian UV-vis double beam spectrophotom-
eter. The large fragments of Bst DNA polymerase were
purchased from New England Biolabs (Beverly, MA, USA). The
RNA extraction kit was purchased from Roche Applied Sciences
(Germany). The cDNA synthesis kit was obtained from Thermo
Scientic. SYBRGold nucleic acid gel stain was purchased from
Molecular Probes (USA). GeneRuler DNA ladder mix was from
Fermentas Life Sciences (Lithuania). Oligonucleotides (Table 2)
were synthesized by Sigma-Aldrich. Gold nanorods were
purchased from Sigma-Aldrich.
3.2. Clinical specimens
The 125 samples were collected from 125 nasopharyngeal swabs
and analyzed from patients admitted to the referenced inu-
enza laboratory in Golestan University of Medical Sciences,
Gorgan, Iran. Initially the RNA was extracted from clinical
nasopharyngeal swabs by using a Roche RNA extraction kit.
Subsequently, cDNA was synthesized by use of a Thermo
Scientic cDNA synthesis kit.
3.3. LAMP process
Reaction mix [12.5 ml; 2 reaction mix; 40 mM Tris–HCl, 20 mM
KCl, 16 mM MgSO4, 20 mM (NH4)2SO4, 0.2% Tween 20, 1.6 M
betain, and 2.8 mM each deoxyribonucleic acid phosphates, pH
8.8], 2.5 ml primer mix (1.6 mM FIP, 1.6 mM BIP, 0.2 mM F3,
0.2 mM B3), 8 U Bst DNA polymerase, and 7 ml distilled water
were dispensed in eachmicrotube up to 25 ml.7,8 Inuenza cDNA
was synthesized from 1 ng RNA sample according to the
manufacturer’s protocol and added to the master mix. For
the negative-control reaction, 2.0 ml distilled water was added to
the microtubes. The solutions were mixed by pipetting and then
spun down. The tubes were set in the block of the cool-hotter
dry bath incubator and incubated at 60 C for 60 min separately.
Then, Bst DNA polymerase was inactivated by incubating the
mixture for 5 min at 80 C to terminate the reaction.7,8
3.4. Oligonucleotides
Primers were selected from published inuenza A virus M gene
nucleic acid sequences encoding the matrix protein (Gene bank
accession no. JX239989), synthesized by Sigma-Aldrich. These
primers amplied a 219 nucleotide fragment of the target cDNA
that includes the species-specic region to identify the inu-
enza A virus (Table 2).
3.5. Colorimetric assay via gold nanorods
In a typical colorimetric experiment, a 20 ml RT-LAMP–GNR mix
contained 5 ml of GNR solution. Aer the LAMP reaction, the
solution immediately was analysed with a UV-vis double beam
spectrophotometer.
3.6. Transmission electron microscopy
Transmission electron microscopy (Philips EM028) was used to
determine the size and morphology of the gold nanorods,This journal is © The Royal Society of Chemistry 2014
Table 2 Oligonucleotide sequences
F3 50 TGGTGC(A/G)CTTGCCAGTTG 30
B3 50 CCAGCCATTTGCTCCATAGC 30
FIPa 50 TGCTGGGAGTCAGCAATCTGTTACAG(G/A)ATGGGGGCTGT(A/G)ACC 30
BIPb 50 AGGCAAATGGTG(G/A)CAACAACCTGTAGTGCTGGCCA(A/G)AACC 30
a FIP, forward internal primer. b BIP, backward internal primer.
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View Article Onlinebefore and aer interaction with the LAMP products. For this
purpose, the samples were immobilized by syringe spraying on
agar scientic holey carbon lm with 300 mesh Cu(50).3.7. Analytical validations
True positives (TP) and true negatives (TN) were determined by
culture results, LAMP results, and the clinician's diagnosis with
false positives (FP) and false negatives (FN) attributed to nd-
ings from the capillary-LAMP assay. Sensitivities and specic-
ities were determined as follows: sensitivity ¼ TP/TP + FN and
specicity ¼ TN/TN + FP.193.8. Limit of detection (LOD) of colorimetric GNR–LAMP
For LOD validation, two sets of serial dilutions (101, 102,
103, 104, 105) from 1 ng viral RNA were provided in diH2O.20
Diluted templates were amplied using LAMP. The rst series
of LAMP products contained GNRs and colorimetric detection
was used. The second ones were detected by gel electrophoresis
stained with SYBRGold.4. Conclusion
To now there have been various reports on using gold
nanoparticles and nucleic acid isothermal amplications for
identication of microorganisms.21–24 Rod-shaped gold nano-
particles, so-called gold nanorods, are another form of gold
nanoparticles but their uses with isothermal amplication
technologies have not yet been introduced. These nanoparticles
are diﬀerent from the spherical gold nanoparticles particularly
due to presence of a CTAB layer leading to positive charges on
their surfaces.25,26 On the other hand, the colorimetric assay via
nucleic acids and GNRs has been described, previously.27 The
assay makes use of the attraction between opposite charges on
nucleic acids and GNRs. In DNA, the negatively charges areas
are due to the phosphate groups of nucleotides.17
In recent years, various nanotechnological methods have
been reported for detection of molecular targets.28–31 As the
most known of nanoparticles, gold nanoparticle probes (GNPs)
have been employed for colorimetric detection of several
nucleic acid amplications (NAAs) such as PCR,32 NASBA
(nucleic acid sequence-based amplication),23 HDA (helicase-
dependent amplication),22 EXPAR (exponential amplication
reaction),33 and LAMP.13 Unmodied gold nanoparticles have
also been used for visualization of single- and double-stranded
DNAs via the electrostatic interaction with colloidal gold
nanoparticles in salt solution.34 Both the gold nanoparticle-This journal is © The Royal Society of Chemistry 2014based detections led to color changes associated with gold
aggregation.
Various reports have applied LAMP technology for molecular
diagnoses of microorganisms.8 Here, we described the appli-
cation of GNRs for direct colorimetric detection of LAMP DNAs
where no covalent functionalization of the gold nanoparticles,
the probe, or the target DNA is required. Because the underlying
adsorption mechanism is electrostatic, the colorimetric assay
may be used simply for nanomolecular detection of target
nucleic acids (e.g. M-gene sequence in human inuenza virus
type A). The phenomenon produces color changes observable
without instrumentation and it needs no electrophoresis or
turbidimetry experiments for assessment of the LAMP results.
In conclusion, adapting rod-shape gold nanoparticles for the
rapid nanomolecular detection of the amplied nucleic acids
via isothermal amplications would simplify the diagnosis of
the genomic materials of pathogenic microorganisms. Hence,
the nanomolecular detection of viruses could alternatively be
introduced for direct detection of amplied DNAs using the
instrumental-based measurements such as uorescent-dyed gel
electrophoresis,18 turbidimetry,11 and enzyme-linked immuno-
sorbent assay35 of LAMP products.Author contributions
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